Purinergic Signalling: Therapeutic Developments
Purinergic signalling, i.e., the role of nucleotides as extracellular signalling molecules, was proposed in 1972. However, this concept was not well accepted until the early 1990's when receptor subtypes for purines and pyrimidines were cloned and characterised, which includes four subtypes of...
Saved in:
Main Author: | Geoffrey Burnstock (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Purinergic mechanosensory transduction and visceral pain
by: Burnstock Geoffrey
Published: (2009) -
ATP-gated P2X receptors in Health and Disease
by: Geoffrey Burnstock
Published: (2015) -
Purinergic Signaling in Neuroinflammation
Published: (2023) -
Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
by: Paola Nobili, et al.
Published: (2022) -
Purinergic Signaling in Health and Disease
Published: (2020)